Browsing by Author Chng, W.J.

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 1 to 20 of 28  next >
Issue DateTitleAuthor(s)
Apr-2012A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancerNg, K.P.; Hillmer, A.M.; Chuah, C.T.H.; Juan, W.C.; Ko, T.K. ; Teo, A.S.M.; Ariyaratne, P.N.; Takahashi, N.; Sawada, K.; Fei, Y.; Soh, S.; Lee, W.H.; Huang, J.W.J.; Allen Jr., J.C.; Woo, X.Y.; Nagarajan, N.; Kumar, V.; Thalamuthu, A.; Poh, W.T.; Ang, A.L.; Mya, H.T.; How, G.F.; Yang, L.Y.; Koh, L.P.; Chowbay, B.; Chang, C.-T.; Nadarajan, V.S.; Chng, W.J.; Than, H.; Lim, L.C.; Goh, Y.T.; Zhang, S.; Poh, D.; Tan, P. ; Seet, J.-E.; Ang, M.-K.; Chau, N.-M.; Ng, Q.-S.; Tan, D.S.W.; Soda, M.; Isobe, K.; Nöthen, M.M.; Wong, T.Y. ; Shahab, A.; Ruan, X.; Cacheux-Rataboul, V.; Sung, W.-K.; Tan, E.H.; Yatabe, Y.; Mano, H.; Soo, R.A. ; Chin, T.M. ; Lim, W.-T.; Ruan, Y. ; Ong, S.T.
20-Jun-2013A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple MyelomaChung, T.-H. ; Mulligan, G.; Fonseca, R.; Chng, W.J.
5-Aug-2013Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 SubtypeNin, D.S. ; Ali, A.B. ; Okumura, K.; Asou, N.; Chen, C.-S.; Chng, W.J.; Khan, M. 
Sep-2013Belinostat and panobinostat (HDACI): In vitro and in vivo studies in thyroid cancerChan, D.; Zheng, Y.; Tyner, J.W.; Chng, W.J.; Chien, W.W. ; Gery, S.; Leong, G.; Braunstein, G.D.; Koeffler, H.P.
2004Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring systemLau, L.G.; Chng, W.J.; Liu, T.C.; Tan, L.K. ; Ong, K.H.; Mow, B.M.F.; Kueh, Y.K. 
2013Clonogenic multiple myeloma cells have shared stemness signature associated with patient survivalReghunathan, R. ; Bi, C.; Liu, S.C.; Loong, K.T.; Chung, T.-H. ; Huang, G. ; Chng, W.J.
Jul-2011Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR proteinNg, A.P.P.; Chng, W.J.; Khan, M. 
2011Determinants of sensitivity to DZNep induced Apoptosis in multiple myeloma cellsXie, Z. ; Bi, C.; Cheong, L.L.; Liu, S.C.; Huang, G. ; Zhou, J. ; Yu, Q.; Chen, C.-S.; Chng, W.J.
Feb-2012Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in miceGuo, K.; Tang, J.P.; Jie, L.; Al-Aidaroos, A.Q.O.; Hong, C.W.; Tan, C.P.B.; Park, J.E.; Varghese, L.; Feng, Z.; Zhou, J. ; Chng, W.J.; Zeng, Q. 
30-May-2013EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.Yan, J. ; Ng, S.B.; Tay, J.L.; Lin, B.; Koh, T.L.; Tan, J.; Selvarajan, V.; Liu, S.C.; Bi, C.; Wang, S.; Choo, S.N.; Shimizu, N.; Huang, G.; Yu, Q.; Chng, W.J.
May-2012Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalitiesBraggio, E.; Dogan, A.; Keats, J.J.; Chng, W.J.; Huang, G. ; Matthews, J.M.; Maurer, M.J.; Law, M.E.; Bosler, D.S.; Barrett, M.; Lossos, I.S.; Witzig, T.E.; Fonseca, R.
Jun-2005Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia [1]Chng, W.J.; Tan, L.H.C. 
Mar-2005Malignant pleural effusion in a patient with multiple myelomaLau, L.G.; Chng, W.J.; Tan, L.H.C. ; Liu, T.C.
Mar-2005Malignant pleural effusion in a patient with multiple myelomaLau, L.G.; Chng, W.J.; Tan, L.H.C. ; Liu, T.C.
1-Aug-2013Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cellsAl-Aidaroos, A.Q.O.; Yuen, H.F.; Guo, K.; Zhang, S.D.; Chung, T.-H. ; Chng, W.J.; Zeng, Q. 
1-Aug-2012Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stressChu, L.; Su, M.Y.; Maggi Jr., L.B.; Lu, L.; Mullins, C.; Crosby, S.; Huang, G. ; Chng, W.J.; Vij, R.; Tomasson, M.H.
Sep-2013Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemiaPark, J.E.; Yuen, H.F.; Zhou, J.B. ; Al-aidaroos, A.Q.O.; Guo, K.; Valk, P.J.; Zhang, S.D.; Chng, W.J.; Hong, C.W.; Mills, K.; Zeng, Q. 
Nov-2011Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaHart, S.; Goh, K.C.; Novotny-Diermayr, V.; Tan, Y.C.; Madan, B.; Amalini, C.; Ong, L.C.; Kheng, B.; Cheong, A.; Zhou, J. ; Chng, W.J.; Wood, J.M.
2013Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in t(4;14) multiple myelomaXie, Z. ; Gunaratne, J.; Cheong, L.L.; Liu, S.C.; Koh, T.L.; Huang, S.; Blackstock, W.P.; Chng, W.J.
9-Dec-2011Regulation of hTERT by BCR-ABL at multiple levels in K562 cellsChai, J.H.; Zhang, Y. ; Tan, W.H.; Chng, W.J.; Li, B.; Wang, X.